PUBLIC COMPANY
saveAFYX Therapeutics A/S
founded 2014 · Hørsholm, Capital Region of Denmark, DKupdated 2mo ago
AFYX Therapeutics A/S is a Danish biopharmaceutical company focused on reformulating and repurposing established pharmaceuticals under a reversed innovation strategy. Its pipeline targets oral inflammatory diseases, head and neck cancer, labor induction and cluster headaches, including the Rivelin biodegradable mucoadhesive patch platform for delivering drugs to mucosal surfaces. The company was formed in 2024 through the merger of AFYX Therapeutics, LionHeart Pharmaceuticals and InPhena.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that